Tremendous advances have been made in understanding the pathogenesis of atypical
Hemolytic Uremic Syndrome (aHUS), an extremely rare disease. Insights into the molecular …

Atypical hemolytic uremic syndrome (aHUS) is a disease characterized by the triad of
microangiopathic hemolytic anemia, thrombocytopenia and acute kidney injury. The …

Background: The management of atypical hemolytic uremic syndrome (aHUS) has evolved
into better control of thrombotic microangiopathy (TMA) and recovery of renal functions since …

Atypical hemolytic uremic syndrome (aHUS) is a rare genetic disorder caused by defective
complement regulation resulting in thrombotic microangiopathy (TMA). Patients can present …

[EN] Haemolytic uraemic syndrome (HUS) is a clinical entitydefined as the triad of
nonimmune haemolytic anaemia, thrombocytopenia, and acute renal failure, in which …

Atypical hemolytic uremic syndrome (aHUS) is a rare thrombotic microangiopathy (TMA)
characterized by the triad of hemolytic anemia, thrombocytopenia, and acute renal failure …

Atypical hemolytic uremic syndrome (aHUS) is a life-threatening thrombotic
microangiopathy, and as many as 70% of patients with aHUS have mutations in the genes …

Atypical hemolytic–uremic syndrome (HUS) is a rare life-threatening disorder characterized
by microangiopathic hemolytic anemia, thrombocytopenia, and ischemic injury to organs …

The 3 major thrombotic microangiopathies (TMAs) are thrombotic thrombocytopenic purpura
(TTP), atypical hemolytic uremic syndrome (aHUS), and Shiga toxin–producing Escherichia …

Atypical hemolytic uremic syndrome (aHUS) is a genetic, life-threatening, chronic disease
that can affect patients of all ages. aHUS is caused by uncontrolled complement activation …